Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

XENETIX 350 INJECTION 350 MGI/ML [SIN08867P]

Active ingredients: IOBITRIDOL

View product's general information
Last updated on 9 October 2026

Product Info

XENETIX 350 INJECTION 350 MGI/ML

[SIN08867P]

Product information

Active Ingredient and Strength

IOBITRIDOL - 76.78 G

Dosage Form

INJECTION

Manufacturer and Country

GUERBET - FRANCE

Registration Number

SIN08867P

Licence Holder

TRANSMEDIC PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

V08AB11

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

4.1. Therapeutic indications

This medicinal product is for diagnostic use only.
Contrast agent for use in:

Xenetix Indications Table 1



Dosing

4.2. Posology and method of administration

The doses must be adapted to the examination and the regions to be opacified, as well as to the body weight and renal function of the subject.
There is no data about the use of Xenetix in pediatric patients. Therefore, the use of Xenetix is not recommended in pediatric patients.
Usually the same iodine concentration and volume are used as with other iodinated X-ray contrast in current use. As with all contrast media, the lowest dose necessary to obtain adequate visualisation should be used.
Adequate hydration should be assured before and after administration as for other contrast media. Usually, the rate of administration varies between 0.5 and 5 ml/s depending on the type of examination.

Xenetix® 300
Recommended mean dosages for intravascular routes:

Xenetix Dosage Table 2



Xenetix® 300
Recommended mean dosages for intracavitary routes:

Xenetix Dosage Table 3



Xenetix® 350
Recommended mean dosages for intravascular routes:

Xenetix Dosage Table 4



Contraindications

4.3. Contraindication

  • Hypersensitivity to iobitridol or any of the excipients.

  • History of a major immediate reaction or delayed skin reaction (see sections 4.4 and 4.8 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information) to a Xenetix® injection.

  • Manifest thyrotoxicosis

  • In the absence of specific studies, myelography is not an indication for Xenetix®.

  • Hysterosalpingography during pregnancy is contraindicated for Xenetix® 300.